DYNE THERAPEUTICS INC (DYN)
US26818M1080 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to DYN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 52.43. This target is 81.66% above the current price.
DYN was analyzed by 14 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about DYN.
In the previous month the buy percentage consensus was at a similar level.
DYN was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-26 | RBC Capital | Initiate | Outperform |
| 2024-11-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-24 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-09-23 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-09-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-03 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-08-16 | Stifel | Maintains | Buy -> Buy |
| 2024-08-15 | Guggenheim | Maintains | Buy -> Buy |
| 2024-08-14 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-08-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-08-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-07-09 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-05-21 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-05-20 | Jefferies | Maintains | Buy -> Buy |
| 2024-05-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-06 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-05-06 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-05-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-30 | Morgan Stanley | Initiate | Overweight |
| 2024-03-26 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-03-08 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-03-07 | Guggenheim | Maintains | Buy -> Buy |
| 2024-03-06 | Stifel | Maintains | Buy -> Buy |
| 2024-03-06 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-03-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-05 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-02-20 | HC Wainwright & Co. | Initiate | Buy |
| 2024-01-04 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2023-08-09 | JP Morgan | Maintains | Overweight -> Overweight |